SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)
BCRX 7.080+0.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (61)1/16/2007 11:53:36 AM
From: scaram(o)uche   of 269
 
Updating........

A research premium of 165m buys you the right to participate in the development of:

1. 4208, milestones and royalties, limited co-promote U.S.

2. frodo, Mundipharma ex-U.S., SPA-restricted pivotal testing LAUNCHED.

3. prammy, intravenous, hospital use and any stockpiling contract revenue.

4. prammy, I.M., seasonal flu.

5. anti-viral (including anti-HCV) and anti-inflammatory pipe (which I have yet to investigate, maybe some of our industry-tuned-in sorts have a feel?).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News